Water Fasting and Chemotherapy for Early-stage Breast Cancer
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 30 (estimated)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Other
This trial is looking for women with early-stage breast cancer who are planning to receive chemotherapy. Participants will fast for 24-48 hours to see if it helps the treatment work better.
You may be able to join if
- I have been diagnosed with invasive breast cancer stage I-III.
- I am planning to receive chemotherapy for 4 cycles.
- I have a BMI of 19.5 or higher.
- I am willing to change my diet.
- I can provide stool samples three times during the study.
You may not be able to join if
- My BMI is below 19.5.
- I have diabetes.
- I have a history of eating disorders.
- I have a serious medical condition.
- I am pregnant or nursing.
- I take medications that must be taken with food.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis research is being done to test the feasibility of 24-48 hours of water-only fasting to improve delivery of 4 cycles of chemotherapy in those receiving breast cancer treatment either before or after surgery.
Loading trial locations…